pindolol has been researched along with bucindolol in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (57.14) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Comer, WT; Deitchman, D; Dennis, RD; Kreighbaum, WE; Matier, WL; Minielli, JL; Perhach, JL | 1 |
Bristow, MR; Handwerger, D; Klein, J; Larrabee, P; Minobe, W; Müller-Beckmann, B; Port, JD; Roden, R; Skerl, L | 2 |
Bristow, MR; Hershberger, RE; Sundberg, L; Wynn, JR | 1 |
Fitzgerald, JD | 1 |
Finch, MJ; Harron, DW; McDevitt, DG; Meredith, PA; O'Connor, PC; Shanks, RG | 1 |
Lefflerová, K; Widimský, J | 1 |
2 review(s) available for pindolol and bucindolol
Article | Year |
---|---|
The possible role of the ancillary properties of beta adrenoceptor antagonists in the management of angina pectoris.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angina Pectoris; Animals; Anxiety Disorders; Bronchial Spasm; Carbohydrate Metabolism; Cardiac Output; Cell Membrane; Dogs; Drug Tolerance; Heart Ventricles; Humans; Labetalol; Lipid Metabolism; Muscle Tonus; Muscle, Smooth, Vascular; Oxygen Consumption; Pindolol; Practolol; Propanolamines; Proteins; Tremor; Vasodilation; Ventricular Fibrillation | 1985 |
Betablockers in the treatment of hypertension (with special emphasis on betablockers with ISA). A review.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Celiprolol; Humans; Hypertension; Labetalol; Middle Aged; Pindolol; Propanolamines | 1988 |
1 trial(s) available for pindolol and bucindolol
Article | Year |
---|---|
Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
Topics: Adrenergic beta-Antagonists; Adult; Heart Rate; Hemodynamics; Humans; Male; Physical Exertion; Pindolol; Propanolamines; Propranolol | 1985 |
4 other study(ies) available for pindolol and bucindolol
Article | Year |
---|---|
Antihypertensive indole derivatives of phenoxypropanolamines with beta-adrenergic receptor antagonist and vasodilating activity.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Hypertension; Indoles; Male; Propanolamines; Rats; Structure-Activity Relationship; Sympathomimetics; Vasodilator Agents | 1980 |
Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Binding, Competitive; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Culture Techniques; Cyclic AMP; Heart Failure; Heart Ventricles; Humans; Iodocyanopindolol; Lymphocytes; Myocardium; Pindolol; Propanolamines; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Vasodilator Agents | 1992 |
Receptor pharmacology of carvedilol in the human heart.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Binding, Competitive; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Cyclic AMP; Guanylyl Imidodiphosphate; Humans; Iodocyanopindolol; Metoprolol; Myocardium; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Vasodilator Agents | 1992 |
Mechanism of action of bucindolol in human ventricular myocardium.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Binding, Competitive; Cell Membrane; Heart; Heart Ventricles; Humans; In Vitro Techniques; Iodocyanopindolol; Lymphocytes; Myocardium; Phenethylamines; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Tetralones | 1990 |